Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Scheinberg

Showing results (301-310 of 426) with videos related to

Pageof 43
Sort By:
Synapse (New York, N.Y.)|October 19, 1999
[(125)I]orphanin FQ/nociceptin binding in Raji cellsJ S Hom, I Goldberg, J Mathis, et al.
Cancer|May 1, 1995
A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanomaL M Minasian, T J Yao, T A Steffens, et al.
Science Advances|January 22, 2025
Microenvironment actuated CAR T cells improve solid tumor efficacy without toxicityKristen C Vogt, Pedro C Silberman, Qianqian Lin, et al.
Molecular Psychiatry|February 21, 2024
HuM195 and its single-chain variable fragment increase Aβ phagocytosis in microglia via elimination of CD33 inhibitory signalingEitan Wong, Manish Malviya, Tanya Jain, et al.
Cancer Research|November 4, 2010
Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumorsFreddy E Escorcia, Erik Henke, Michael R McDevitt, et al.
International Journal of Nanomedicine|November 3, 2010
Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubesAlessandro Ruggiero, Carlos H Villa, Jason P Holland, et al.
Blood|February 26, 2000
Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responsesJ Pinilla-Ibarz, K Cathcart, T Korontsvit, et al.
Oncoimmunology|June 9, 2021
Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapyAngel Charles, Christopher M Bourne, Tanya Korontsvit, et al.
Blood|June 26, 2004
Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramersRui Rong Yuan, Phillip Wong, Michael R McDevitt, et al.
Leukemia Research|March 10, 2005
Immune therapy of chronic myelogenous leukemiaRobert Peter Gale, Mary M Horowitz, Moshe Talpaz, et al.
Pageof 43

Showing results (301-310 of 426) with videos related to

Sort By:
Pageof 43
Synapse (New York, N.Y.)|October 19, 1999
[(125)I]orphanin FQ/nociceptin binding in Raji cellsJ S Hom, I Goldberg, J Mathis, et al.
Cancer|May 1, 1995
A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanomaL M Minasian, T J Yao, T A Steffens, et al.
Science Advances|January 22, 2025
Microenvironment actuated CAR T cells improve solid tumor efficacy without toxicityKristen C Vogt, Pedro C Silberman, Qianqian Lin, et al.
Molecular Psychiatry|February 21, 2024
HuM195 and its single-chain variable fragment increase Aβ phagocytosis in microglia via elimination of CD33 inhibitory signalingEitan Wong, Manish Malviya, Tanya Jain, et al.
Cancer Research|November 4, 2010
Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumorsFreddy E Escorcia, Erik Henke, Michael R McDevitt, et al.
International Journal of Nanomedicine|November 3, 2010
Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubesAlessandro Ruggiero, Carlos H Villa, Jason P Holland, et al.
Blood|February 26, 2000
Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responsesJ Pinilla-Ibarz, K Cathcart, T Korontsvit, et al.
Oncoimmunology|June 9, 2021
Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapyAngel Charles, Christopher M Bourne, Tanya Korontsvit, et al.
Blood|June 26, 2004
Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramersRui Rong Yuan, Phillip Wong, Michael R McDevitt, et al.
Leukemia Research|March 10, 2005
Immune therapy of chronic myelogenous leukemiaRobert Peter Gale, Mary M Horowitz, Moshe Talpaz, et al.
Pageof 43